Abbott Molecular Inc.

Abbott Laboratories Corporation

Wai-Bing X Mak

Brian J Erickson

Shihai X Huang

Klara Abravaya

John A Salituro

Ning Tang

Dominik Duelli

Edward N Granados

Gerard J Gundling

Natalie A Solomon

Magdalena Szostak

Amanda Goldston

Robert Kowal

The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis B virus (HBV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Assay for detecting hepatitis B virus (HBV)

The invention provides methods for isolating DNA from a blood sample collected into tubes containing a rapid clot activator, which involves the use of a lysis buffer comprising an alcohol.

Maximizing DNA yield of blood specimens collected in rapid clot tubes

The present invention relates to primers, probes, primer sets, primer and probe sets, methods and kits for detecting human papillomaviruses, human beta globin sequences and human papillomaviruses and human beta globin sequences in a test sample.

Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

The present disclosure relates to systems and methods for nucleic acid isolation. In particular, the present disclosure provides systems and methods for isolating low molecular weight circulating nucleic acids from bodily fluids (e.g., plasma).

Systems and methods for isolating nucleic acids

Growing community of inventors

Cary, IL, United States of America

Wai-Bing X Mak